logo-loader
HealthCannabis
Xphyto Therapeutics Corp.

Full interview: Xphyto Therapeutics partner Bunker signs agreement with University of Munich

Xphyto Therapeutics (CSE: XPHY) VP European Corporate Development and Managing Director at Bunker, Robert Barth joined Steve Darling on Skype from Germany with news the company has signed an agreement with the University of Munich and their Department of Bio-Chemistry. 

Barth talks about what research they will do together and also when their facility “The Bunker” will be up and running.

Quick facts: Xphyto Therapeutics Corp.

Price: $1.31

Market: CSE
Market Cap: $61.71 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Xphyto Therapeutics Corp. named herein, including the promotion by the Company of Xphyto Therapeutics Corp. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Linius Technologies updates from the International...

Linius Technologies Ltd (ASX:LNU) CEO Chris Richardson speaks to Proactive London's Andrew Scott from the International Broadcasting Convention in Amsterdam. ''Linius is here in conjunction with our partner IBM working with them and releasing for the first time the DATN ( digital asset trust...

6 hours, 22 minutes ago

2 min read